Stephens Investment Management Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $150M | Sell |
475,609
-19,061
| -4% | -$4.49M | 1.61% | 3 |
|
|
2026
Q1 | $98.8M | Sell |
494,670
-6,370
| -1% | -$1.26M | 1.35% | 11 |
|
|
2025
Q4 | $94.7M | Sell |
501,040
-53,502
| -10% | -$10.3M | 1.23% | 16 |
|
|
2025
Q3 | $98.2M | Sell |
554,542
-50,271
| -8% | -$7.47M | 1.27% | 14 |
|
|
2025
Q2 | $68.8M | Sell |
604,813
-2,409
| -0.4% | -$257K | 0.91% | 42 |
|
|
2025
Q1 | $63.8M | Sell |
607,222
-5,560
| -0.9% | -$629K | 0.92% | 36 |
|
|
2024
Q4 | $65.7M | Sell |
612,782
-5,914
| -1% | -$669K | 0.88% | 38 |
|
|
2024
Q3 | $61.9M | Sell |
618,696
-33,304
| -5% | -$3.35M | 0.84% | 46 |
|
|
2024
Q2 | $54.9M | Sell |
652,000
-44,758
| -6% | -$3.56M | 0.77% | 55 |
|
|
2024
Q1 | $50.9M | Buy |
696,758
+37,324
| +6% | +$2.75M | 0.68% | 68 |
|
|
2023
Q4 | $47.1M | Buy |
659,434
+191,870
| +41% | +$11.3M | 0.69% | 70 |
|
|
2023
Q3 | $28M | Buy |
467,564
+1,154
| +0.2% | +$76K | 0.46% | 93 |
|
|
2023
Q2 | $33.6M | Buy |
466,410
+11,321
| +2% | +$849K | 0.52% | 88 |
|
|
2023
Q1 | $33.5M | Buy |
455,089
+673
| +0.1% | +$47.8K | 0.56% | 85 |
|
|
2022
Q4 | $30.7M | Sell |
454,416
-269,720
| -37% | -$17.5M | 0.56% | 83 |
|
|
2022
Q3 | $38.9M | Sell |
724,136
-2,943
| -0.4% | -$173K | 0.74% | 62 |
|
|
2022
Q2 | $40.5M | Buy |
727,079
+57,554
| +9% | +$3.27M | 0.75% | 63 |
|
|
2022
Q1 | $47M | Buy |
669,525
+10,117
| +2% | +$734K | 0.69% | 71 |
|
|
2021
Q4 | $63.5M | Buy |
659,408
+1,915
| +0.3% | +$177K | 0.82% | 45 |
|
|
2021
Q3 | $57.1M | Buy |
657,493
+74,974
| +13% | +$5.8M | 0.78% | 53 |
|
|
2021
Q2 | $47.7M | Sell |
582,519
-11,889
| -2% | -$989K | 0.65% | 71 |
|
|
2021
Q1 | $56.5M | Sell |
594,408
-339,009
| -36% | -$32M | 0.82% | 52 |
|
|
2020
Q4 | $57.9M | Sell |
933,417
-19,746
| -2% | -$1.13M | 0.86% | 49 |
|
|
2020
Q3 | $56.7M | Sell |
953,163
-46,973
| -5% | -$3.21M | 1% | 34 |
|
|
2020
Q2 | $69.8M | Buy |
1,000,136
+70,997
| +8% | +$4.5M | 1.26% | 14 |
|
|
2020
Q1 | $42.1M | Buy |
929,139
+114,655
| +14% | +$6.5M | 1.02% | 35 |
|
|
2019
Q4 | $53M | Sell |
814,484
-5,098
| -0.6% | -$341K | 1% | 40 |
|
|
2019
Q3 | $50.9M | Buy |
819,582
+110,756
| +16% | +$6.95M | 1.02% | 34 |
|
|
2019
Q2 | $50.5M | Buy |
708,826
+26,519
| +4% | +$1.95M | 0.96% | 34 |
|
|
2019
Q1 | $53.5M | Buy |
682,307
+27,730
| +4% | +$2.1M | 1.09% | 25 |
|
|
2018
Q4 | $55.4M | Buy |
654,577
+41,537
| +7% | +$4.43M | 1.31% | 10 |
|
|
2018
Q3 | $105M | Sell |
613,040
-53,553
| -8% | -$8.07M | 1.94% | 1 |
|
|
2018
Q2 | $86.5M | Sell |
666,593
-14,777
| -2% | -$1.65M | 1.74% | 2 |
|
|
2018
Q1 | $70.2M | Sell |
681,370
-7,494
| -1% | -$741K | 1.52% | 6 |
|
|
2017
Q4 | $58.8M | Sell |
688,864
-34,454
| -5% | -$2.99M | 1.34% | 10 |
|
|
2017
Q3 | $61.4M | Buy |
723,318
+4,728
| +0.7% | +$374K | 1.42% | 10 |
|
|
2017
Q2 | $54.4M | Sell |
718,590
-322
| -0% | -$22.5K | 1.31% | 11 |
|
|
2017
Q1 | $47.5M | Buy |
718,912
+53,130
| +8% | +$3.5M | 1.17% | 19 |
|
|
2016
Q4 | $42.2M | Buy |
665,782
+42,055
| +7% | +$2.65M | 1.18% | 21 |
|
|
2016
Q3 | $39.7M | Buy |
623,727
+49,100
| +9% | +$3.61M | 1.18% | 20 |
|
|
2016
Q2 | $42.8M | Sell |
574,627
-44,557
| -7% | -$3.31M | 1.4% | 10 |
|
|
2016
Q1 | $41.4M | Sell |
619,184
-4,861
| -0.8% | -$295K | 1.45% | 7 |
|
|
2015
Q4 | $42.2M | Sell |
624,045
-12,750
| -2% | -$787K | 1.49% | 7 |
|
|
2015
Q3 | $34M | Sell |
636,795
-45,793
| -7% | -$2.78M | 1.2% | 22 |
|
|
2015
Q2 | $43M | Sell |
682,588
-43,457
| -6% | -$2.37M | 1.27% | 15 |
|
|
2015
Q1 | $34.9M | Buy |
726,045
+5,381
| +0.7% | +$206K | 1.04% | 29 |
|
|
2014
Q4 | $23.9M | Sell |
720,664
-28,915
| -4% | -$941K | 0.71% | 56 |
|
|
2014
Q3 | $22M | Buy |
749,579
+229,728
| +44% | +$7.63M | 0.66% | 59 |
|
|
2014
Q2 | $20.2M | Buy |
519,851
+56,698
| +12% | +$2.3M | 0.62% | 63 |
|
|
2014
Q1 | $19.4M | Buy |
463,153
+100,354
| +28% | +$4.18M | 0.59% | 68 |
|
|
2013
Q4 | $11.9M | Buy |
362,799
+60,000
| +20% | +$1.95M | 0.4% | 104 |
|
|
2013
Q3 | $8.18M | Buy |
+302,799
| New | +$8.52M | 0.28% | 118 |
|
Other funds holding LGND
JT
CAM
Stephens Investment Management Group's LGND Position: Q2 2026 in Review
Stephens Investment Management Group reduced its Ligand Pharmaceuticals (LGND) stake by 3.9% in Q2 2026, selling an estimated $4.49M and leaving 475,609 shares worth $150M. The position accounts for 1.61% of the portfolio, ranked #3.
Stephens Investment Management Group first reported a position in LGND in Q3 2013 and has held it in 52 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Stephens Investment Management Group held 475,609 shares of Ligand Pharmaceuticals worth $150M as of Q2 2026.
- Stephens Investment Management Group sold 19,061 Ligand Pharmaceuticals shares in Q2 2026, an estimated $4.49M.
- Ligand Pharmaceuticals made up 1.61% of Stephens Investment Management Group's portfolio in Q2 2026, its #3 holding.
- Stephens Investment Management Group first reported a position in Ligand Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Stephens Investment Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.